
Inorganica Chimica Acta p. 147 - 150 (1996)
Update date:2022-08-04
Topics:
Malisch, Wolfgang
Hahner, Christoph
Gruen, Klaus
Reising, Joachim
Goddard, Richard
Krueger, Carl
[2+2] Cycloaddition of the prostereogenic phosphenium complexes Cp(OC)2M=P(o-Tol)Ph (M = Mo (1a), W (1b)) with the isocyanates RNCO (R=Et (2a), Ph (2b)) leads to the formation of the four-membered phosphametallacycles Cp(OC)2M-P(o-Tol) (Ph)-C(O)-NR (M = Mo, W; R = Et, Ph) (3a-c) with high diastereoselectivity. The X-ray crystal structure of Cp(OC)2W-P(o-Tol) (Ph) -C(O)-NEt (3b) reveals that the preferred diastereomer is characterized by a syn arrangement of the tolyl ligand and the cyclopentadienyl unit.
Jinan Hongfangde Pharmatech Co.LTD
Contact:0531-88870908
Address:F Bldg,750#,Shunhua Rd,New&High-tech Zone,Jinan,Shandong,China 250101
Shanghai KFSL Pharmaceutical Technology Co.,Ltd.
Contact:+86-21-39971718
Address:859 jiadingchengliu shanghai
Contact:+86-577-65618087-605
Address:Room 402, Unit 4 Xinhu Bldg. Waitan Ruian City, Zhejiang China.
Shanxi Tongji Pharmaceuticals Co., Ltd.
Contact:+86-359-3024784
Address:Xikuang South Road, Ruicheng County , Shanxi
CHANGZHOU HANGYU PHARMACEUTICAL TECHNOLOGY CO., LTD
website:http://www.czyys.com
Contact:0086-519-88802789
Address:No.300,Yanling Middle Road, Changzhou, Jiangsu, China
Doi:10.1021/ja9824829
(1999)Doi:10.1016/S0040-4020(97)00650-9
(1997)Doi:10.1016/0040-4039(96)00595-3
(1996)Doi:10.1016/0957-4166(96)00114-0
(1996)Doi:10.1139/v68-126
(1968)Doi:10.1016/S0040-4039(01)89940-8
(1967)